Centre for Eye Research Australia
Glaucoma surgery is a highly effective way of preserving sight, but like most treatments, it comes with challenges.
The medicine that is currently used after surgery, which reduces scarring, is toxic and carries a risk of vision loss.
Now researchers from across CERA are working to investigate if gene therapy can be used to combat scarring instead.
"We want to go straight to the source of scarring," says Dr Jennifer Fan Gaskin
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
